TOAGF yields 4.71% · MRK yields 2.76%● Live data
📍 TOAGF pulled ahead of the other in Year 1
Combined, TOAGF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOAGF + MRK for your $10,000?
Toagosei Co., Ltd., together with its subsidiaries, manufactures, distributes, and sells chemical products in Japan and internationally. The company operates through Commodity Chemicals, Polymer & Oligomer, Adhesive Material, Performance Chemicals, and Plastics segment. It offers inorganic products, including liquid caustic soda, liquid chlorine, synthetic hydrochloric acid, sodium hypochlorite, caustic and super potash, sulfuric acid, sodium sulfite, potassium pyrophosphate, and copper oxide, as well as iron perchloride, hypochiorous acid, copper pyrophosphate, and copper potassium pyrophosphate solutions; chlorinated solvents, such as trichlorethylene and tetrachlorethylene; and ammonium sulfate and potassium bicarbonate fertilizers. The company also provides acrylic monomers; acrylamide tertiary butyl sulfonic acid and ethylene carbonate; acrylic polymers, such as dispersants, thickeners, scale inhibitors, pressure sensitive adhesives, binders, paint vehicles, and gelling agents; special polymers; solvent-free acrylic polymers; special acrylic monomers; polymer flocculants; and UV-curable resins. Further, the company provides instant glues and functional adhesives; inorganic chemicals, such as liquid hydrogen chloride, and hexachlorodisilane, as well as potassium hydroxide and carbonate aqueous, and ferric chloride solutions; and inorganic functional materials, including electronic materials and amenity care materials. Additionally, it offers industrial gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, and mixed gas; and products for the construction and civil engineering. The company was founded in 1933 and is headquartered in Tokyo, Japan.
Full TOAGF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.